Science
The only Vitamin K2 shaped strictly by data confirming true health benefits: MenaQ7®
Being able to say an ingredient is clinically validated takes an overwhelming investment and commitment, which is the exact course that has shaped the MenaQ7® Vitamin K2 as MK-7 on the market today.
Today’s understanding of Vitamin K2 is based solely on MenaQ7®, the source material for more than 22 human clinical trials (with more underway) demonstrating safe, efficacious benefits for human health. And those studies were published in respected peer-reviewed journals:
MenaQ7® and Cardiovascular Health
- Vermeer C and Vik H. Vascular Diseases and Therapeutics. 2020
- Mansour et al. Journal of the American Society of Hypertension. 2017
- Aoun et al. BMC Nephrology. 2017
- Knapen et al. European Journal of Clinical Nutrition. 2016
- Knapen et al. Journal of Nutritional Science. 2015
- Kurnatowska et al. Polish Archives of Internal Medicine. 2015
- Knapen et al. Thrombosis and Haemostasis. 2015
- Theuwissen et al. British Journal of Nutrition. 2012
- Chatrou et al. Blood Review. 2012
- Dalmeijer et al. Atherosclerosis. 2012
MenaQ7® in Diseased Populations
- Mansour et al. Journal of the American Society of Hypertension. 2017
- Aoun et al. BMC Nephrology. 2017
- Kurnatowska et al. Polish Archive of Internal Medicine, 2015
- Calwue et al. Nephrology Dialysis Transplant. 2014
- Ozdemir et al. Journal Pediatric Hematology Oncology. 2013
- Westenfeld et al. American Journal of Kidney Disease. 2012
MenaQ7® in Healthy Populations and Children’s Health
MenaQ7® for Optimal Bioavailability
This commitment to scientific research and clinical validation has earned MenaQ7® the VitaK2™ Seal of Quality and Efficacy from the world’s leading experts in vitamin K.
MenaQ7® is featured in quality products around the globe.
